Regulation of neuroimmune processes by damage- and resolution-associated molecular patterns
Open Access
- 22 September 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 16 (3) , 423-429
Abstract
Sterile inflammatory processes are essential for the maintenance of central nervous system homeostasis, but they also contribute to various neurological disorders, including neurotrauma, stroke, and demyelinating or neurodegenerative diseases. Immune mechanisms in the central nervous system and periphery are regulated by a diverse group of endogenous proteins, which can be broadly divided into the pro-inflammatory damage-associated molecular patterns (DAMPs) and anti-inflammatory resolution-associated molecular patterns (RAMPs), even though there is notable overlap between the DAMP- and RAMP-like activities for some of these molecules. Both groups of molecular patterns were initially described in peripheral immune processes and pathologies; however, it is now evident that at least some, if not all, of these immunomodulators also regulate neuroimmune processes and contribute to neuroinflammation in diverse central nervous system disorders. The review of recent literature demonstrates that studies on DAMPs and RAMPs of the central nervous system still lag behind the much broader research effort focused on their peripheral counterparts. Nevertheless, this review also reveals that over the last five years, significant advances have been made in our understanding of the neuroimmune functions of several well-established DAMPs, including high-mobility group box 1 protein and interleukin 33. Novel neuroimmune functions have been demonstrated for other DAMPs that previously were considered almost exclusively as peripheral immune regulators; they include mitochondrial transcription factor A and cytochrome C. RAMPs of the central nervous system are an emerging area of neuroimmunology with very high translational potential since some of these molecules have already been used in preclinical and clinical studies as candidate therapeutic agents for inflammatory conditions, such as multiple sclerosis and rheumatoid arthritis. The therapeutic potential of DAMP antagonists and neutralizing antibodies in central nervous system neuroinflammatory diseases is also supported by several of the identified studies. It can be concluded that further studies of DAMPs and RAMPs of the central nervous system will continue to be an important and productive field of neuroimmunology.Keywords
This publication has 94 references indexed in Scilit:
- The C-terminal decapeptide of prothymosin α is responsible for its stimulatory effect on the functions of human neutrophils in vitroInternational Immunopharmacology, 2013
- Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophagesProceedings of the National Academy of Sciences, 2012
- Resolution-associated molecular patterns (RAMP): RAMParts defending immunological homeostasis?Clinical and Experimental Immunology, 2011
- Uptake of Oxidized Low Density Lipoprotein by CD36 Occurs by an Actin-dependent Pathway Distinct from MacropinocytosisJournal of Biological Chemistry, 2009
- Monocyte activation by necrotic cells is promoted by mitochondrial proteins and formyl peptide receptorsCritical Care Medicine, 2009
- HMGB1 loves companyJournal of Leukocyte Biology, 2009
- Molecular chaperone‐mediated tau protein metabolism counteracts the formation of granular tau oligomers in human brainJournal of Neuroscience Research, 2007
- Heat Shock Proteins 70 and 90 Inhibit Early Stages of Amyloid β-(1–42) Aggregation in VitroJournal of Biological Chemistry, 2006
- BiP/GRP78-Induced Production of Cytokines and Uptake of Amyloid-β(1-42) Peptide in MicrogliaBiochemical and Biophysical Research Communications, 2001
- The Chaperone BiP/GRP78 Binds to Amyloid Precursor Protein and Decreases Aβ40 and Aβ42 SecretionJournal of Biological Chemistry, 1998